SI1633355T1 - Derivati benzotiazola in njihova uporaba pri zdravljenju bolezni, povezanih z receptorjem a2a adenozina - Google Patents
Derivati benzotiazola in njihova uporaba pri zdravljenju bolezni, povezanih z receptorjem a2a adenozinaInfo
- Publication number
- SI1633355T1 SI1633355T1 SI200430752T SI200430752T SI1633355T1 SI 1633355 T1 SI1633355 T1 SI 1633355T1 SI 200430752 T SI200430752 T SI 200430752T SI 200430752 T SI200430752 T SI 200430752T SI 1633355 T1 SI1633355 T1 SI 1633355T1
- Authority
- SI
- Slovenia
- Prior art keywords
- adenosine
- receptor
- treatment
- diseases related
- benzothiazole derivatives
- Prior art date
Links
- 102000007471 Adenosine A2A receptor Human genes 0.000 title 1
- 108010085277 Adenosine A2A receptor Proteins 0.000 title 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03012118 | 2003-05-30 | ||
| PCT/EP2004/005474 WO2004105755A1 (en) | 2003-05-30 | 2004-05-21 | Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
| EP04734217A EP1633355B1 (en) | 2003-05-30 | 2004-05-21 | Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1633355T1 true SI1633355T1 (sl) | 2008-08-31 |
Family
ID=33442738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200430752T SI1633355T1 (sl) | 2003-05-30 | 2004-05-21 | Derivati benzotiazola in njihova uporaba pri zdravljenju bolezni, povezanih z receptorjem a2a adenozina |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7285548B2 (sl) |
| EP (1) | EP1633355B1 (sl) |
| JP (1) | JP4426572B2 (sl) |
| KR (1) | KR100765566B1 (sl) |
| CN (1) | CN1798558B (sl) |
| AR (1) | AR044569A1 (sl) |
| AT (1) | ATE396726T1 (sl) |
| AU (1) | AU2004243481B2 (sl) |
| BR (1) | BRPI0410878A (sl) |
| CA (1) | CA2527174C (sl) |
| CL (1) | CL2004001272A1 (sl) |
| DE (1) | DE602004014138D1 (sl) |
| DK (1) | DK1633355T3 (sl) |
| ES (1) | ES2307015T3 (sl) |
| HR (1) | HRP20080318T3 (sl) |
| IL (1) | IL171769A (sl) |
| MX (1) | MXPA05012772A (sl) |
| MY (1) | MY138018A (sl) |
| NO (1) | NO20055176L (sl) |
| NZ (1) | NZ543372A (sl) |
| PL (1) | PL1633355T3 (sl) |
| PT (1) | PT1633355E (sl) |
| RU (1) | RU2348629C2 (sl) |
| SI (1) | SI1633355T1 (sl) |
| TW (1) | TW200508230A (sl) |
| WO (1) | WO2004105755A1 (sl) |
| ZA (1) | ZA200509608B (sl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2369256T3 (es) * | 2000-06-26 | 2011-11-28 | Helen Of Troy Limited | Sistema de lámpara recargable. |
| BRPI0513510A (pt) * | 2004-07-22 | 2008-05-06 | Hoffmann La Roche | benzotiazóis substituìdos |
| US8247609B2 (en) * | 2005-10-25 | 2012-08-21 | Pharamleads | Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors |
| GB0622826D0 (en) * | 2006-11-15 | 2006-12-27 | Acurepharma Ab | Novel amides acting on the adenosine receptors |
| WO2010140339A1 (ja) * | 2009-06-01 | 2010-12-09 | 武田薬品工業株式会社 | 複素環化合物 |
| BR112015014145B1 (pt) | 2012-12-21 | 2020-12-29 | Janssen Sciences Ireland Uc | compostos antibacterianos, composição farmacêutica, seus processos de preparação e combinação |
| DE102019110904B4 (de) | 2019-04-26 | 2022-01-20 | Helmholtz-Zentrum Dresden - Rossendorf E. V. | N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE385794T1 (de) * | 2000-06-21 | 2008-03-15 | Hoffmann La Roche | Benzothiazolderivate zur behandlung von alzheimer und parkinson |
| US6727247B2 (en) * | 2001-12-10 | 2004-04-27 | Hoffman-La Roche Inc. | Substituted benzothiazole amide derivatives |
-
2004
- 2004-05-21 WO PCT/EP2004/005474 patent/WO2004105755A1/en active IP Right Grant
- 2004-05-21 DK DK04734217T patent/DK1633355T3/da active
- 2004-05-21 BR BRPI0410878-7A patent/BRPI0410878A/pt not_active Application Discontinuation
- 2004-05-21 PT PT04734217T patent/PT1633355E/pt unknown
- 2004-05-21 CN CN2004800148906A patent/CN1798558B/zh not_active Expired - Fee Related
- 2004-05-21 MX MXPA05012772A patent/MXPA05012772A/es active IP Right Grant
- 2004-05-21 PL PL04734217T patent/PL1633355T3/pl unknown
- 2004-05-21 AU AU2004243481A patent/AU2004243481B2/en not_active Ceased
- 2004-05-21 AT AT04734217T patent/ATE396726T1/de active
- 2004-05-21 ES ES04734217T patent/ES2307015T3/es not_active Expired - Lifetime
- 2004-05-21 RU RU2005141307/04A patent/RU2348629C2/ru not_active IP Right Cessation
- 2004-05-21 CA CA2527174A patent/CA2527174C/en not_active Expired - Fee Related
- 2004-05-21 DE DE602004014138T patent/DE602004014138D1/de not_active Expired - Lifetime
- 2004-05-21 EP EP04734217A patent/EP1633355B1/en not_active Expired - Lifetime
- 2004-05-21 KR KR1020057022791A patent/KR100765566B1/ko active IP Right Grant
- 2004-05-21 SI SI200430752T patent/SI1633355T1/sl unknown
- 2004-05-21 NZ NZ543372A patent/NZ543372A/en unknown
- 2004-05-21 JP JP2006508188A patent/JP4426572B2/ja not_active Expired - Fee Related
- 2004-05-26 TW TW093114971A patent/TW200508230A/zh unknown
- 2004-05-26 US US10/854,059 patent/US7285548B2/en not_active Expired - Fee Related
- 2004-05-26 CL CL200401272A patent/CL2004001272A1/es unknown
- 2004-05-27 MY MYPI20042036A patent/MY138018A/en unknown
- 2004-05-28 AR ARP040101840A patent/AR044569A1/es not_active Application Discontinuation
-
2005
- 2005-11-03 NO NO20055176A patent/NO20055176L/no unknown
- 2005-11-03 IL IL171769A patent/IL171769A/en active IP Right Grant
- 2005-11-28 ZA ZA200509608A patent/ZA200509608B/en unknown
-
2008
- 2008-07-02 HR HR20080318T patent/HRP20080318T3/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1089376A1 (en) | Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions | |
| IL173395A0 (en) | Pyridazine derivatives and their use as therapeutic agents | |
| HK1137922A1 (en) | Benzothiazepine derivatives as ryanodine receptor (ryr2) inhibitors and their use in the treatment of cardiac diseases | |
| SI1928886T1 (sl) | Derivati piridina in njihova uporaba pri zdravljenju psihotiäśnih motenj | |
| HK1089155A1 (en) | Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders | |
| PL1641918T3 (pl) | Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia | |
| IL178012A0 (en) | Diphenyl-indol-2-on compounds and their use in the treatment of cancer | |
| IL177369A0 (en) | Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain | |
| HUP0401987A3 (en) | Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments | |
| ZA200410401B (en) | Use of thio-oxindole derivatives in treatment of skin disorders | |
| NO20043370L (no) | N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer | |
| IL171769A (en) | Benzothiazole derivatives, process for their preparation, use thereof in the manufacture of medicaments for the treatment of diseases related to the adenosine a2a receptor and medicaments comprising said derivatives | |
| IL197298A0 (en) | Novel 5,7-disubstituted (1,3)thiazolo [4,5-d]pyrimidin-2 (3h)-amine derivatives and their use in therapy | |
| GB0420734D0 (en) | Improvements in or relating to the therapeutic use of radiation and apparatus therefor | |
| EP1881987A4 (en) | PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES | |
| IL185586A0 (en) | 1,2,4-triazine derivatives, preparation and use thereof in human therapy | |
| PL1628662T3 (pl) | Pochodne benzotiazolu i ich zastosowanie w leczeniu chorób związanych z receptorem adenozynowym A2A | |
| GB0504787D0 (en) | Composition for use in the treatment of dry skin conditions | |
| IL162941A0 (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
| AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
| AU2003245858A8 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases | |
| NO20030811D0 (no) | Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer | |
| AU2003255337A8 (en) | Use of genes identified to be involved in tumor development for the development of anti-cancer drugs | |
| IL163431A (en) | 1 - phenyl - 2 - heteroaryl - substituted benzimidazole derivatives and the use thereof for producing drugs used in the treatment of immunological diseases | |
| GB0207596D0 (en) | Improvements in or relating to patient support structures and their use |